Security key
87990A106
Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)
CUSIP: 87990A106
Q4 2021 13F Holders as of 31 Dec 2021
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 35,354,543
- Total 13F value
- $667,600,957
- Share change
- +996,186
- SEC-reported price per share
- $18.95
- Number of holders
- 46
- Value change
- +$18,069,398
- Number of buys
- 25
- Number of sells
- 8
- Shares outstanding
- 213,832,909
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2021
Institutions
46
Top holders
10
TNYA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2022
Previous quarter: Q3 2021
Tenaya Therapeutics, Inc. SEC filings
Tenaya Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87990A106
Recent filing periods:
Ownership snapshot
Top reported holders of TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Column Group LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F
Lead comparable stake: 4.4%
Showing 1-6 of 15 holder rows.
Quick read
Column Group LLC leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Column Group LLC's linked filing trail.
Comparable ownership
Top 5
Column Group LLC
4.4%
FMR LLC
2.4%
Casdin Capital, LLC
1.7%
RA CAPITAL MANAGEMENT, L.P.
1.7%
PRICE T ROWE ASSOCIATES INC /MD/
1.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Column Group LLC |
13F
Company
|
4.4%
|
$194,116
9,400,290 shares
|
— | 30 Sep 2021 |
| FMR LLC |
13F
Company
|
2.4%
|
$102,065,000
5,103,477 shares
|
— | 30 Sep 2021 |
| Casdin Capital, LLC |
13F
Company
|
1.7%
|
$74,068,000
3,586,818 shares
|
— | 30 Sep 2021 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
1.7%
|
$73,339,000
3,551,508 shares
|
— | 30 Sep 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
1.3%
|
$56,019,000
2,773,109 shares
|
— | 30 Sep 2021 |
| RTW INVESTMENTS, LP |
13F
Company
|
1.1%
|
$48,581,000
2,458,750 shares
|
— | 30 Sep 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
46
Shares
35,354,543
Rows available
46
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
44
Q4 2021 holders
46
Holder diff
2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 value | Q4 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend